1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE structure
|
Common Name | 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | ||
|---|---|---|---|---|
| CAS Number | 998-07-2 | Molecular Weight | 635.853 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 685.6±65.0 °C at 760 mmHg | |
| Molecular Formula | C33H66NO8P | Melting Point | 193 °C | |
| MSDS | Chinese USA | Flash Point | 368.5±34.3 °C | |
| Name | 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 685.6±65.0 °C at 760 mmHg |
| Melting Point | 193 °C |
| Molecular Formula | C33H66NO8P |
| Molecular Weight | 635.853 |
| Flash Point | 368.5±34.3 °C |
| Exact Mass | 635.452576 |
| PSA | 144.19000 |
| LogP | 11.58 |
| Vapour Pressure | 0.0±4.6 mmHg at 25°C |
| Index of Refraction | 1.474 |
| Storage condition | −20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~%
1,2-DIMYRISTOYL... CAS#:998-07-2 |
| Literature: Bulletin de la Societe Chimique de France, , vol. 130, p. 575 - 583 |
|
~%
1,2-DIMYRISTOYL... CAS#:998-07-2 |
| Literature: Bulletin de la Societe Chimique de France, , vol. 130, p. 575 - 583 |
CAS#:544-63-8
CAS#:18194-24-6|
Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry.
Rapid Commun. Mass Spectrom. 29 , 1491-500, (2015) Although serotonin deficiency is involved with various physiological disorders such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression, the serotonin-dependent pathomechanisms r... |
|
|
Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature.
Nano Lett. 15 , 3008-16, (2015) Targeted RNA delivery to lung endothelial cells has the potential to treat conditions that involve inflammation, such as chronic asthma and obstructive pulmonary disease. To this end, chemically modif... |
|
|
Phospholipids profiling and outcome of peritoneal dialysis patients.
Biomarkers 19(6) , 505-8, (2014) To investigate phospholipids (PLs) biomarkers in predicting outcome of patients undergoing peritoneal dialysis (PD).Twenty PD patients were followed using baseline plasma PLs with an improved online t... |
| Tetradecanoic acid, (1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester |
| (2R)-3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl myristate |
| [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tetradecanoate |
| MFCD00036775 |